The Oncologist Online -- Table of Contents Volume 10, Supplement 1 , 2005

Volume 10, Supplement 1 , 2005 [Index by author]

Bisphosphonates in Metastatic Bone Disease: Renal Safety Matters

Find articles in this issue containing these words:
[Search ALL Issues]

Receive this page by email each issue: [Sign up for eTOCs]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Bisphosphonates in Metastatic Bone Disease: Renal Safety Matters: Jean-Jacques Body
The Oncologist 2005; 10(Supplement 1 ): 1-2; doi:10.1634/theoncologist.10-90001-1
[Full Text] [PDF]

Preclinical Perspectives on Bisphosphonate Renal Safety: Jean-Jacques Body, Thomas Pfister, Frieder Bauss
The Oncologist 2005; 10(Supplement 1 ): 3-7; doi:10.1634/theoncologist.10-90001-3
[Abstract] [Full Text] [PDF]

Efficacy of Ibandronate in Metastatic Bone Disease: Review of Clinical Data: Richard Bell
The Oncologist 2005; 10(Supplement 1 ): 8-13; doi:10.1634/theoncologist.10-90001-8
[Abstract] [Full Text] [PDF]

Renal Safety of Ibandronate: Graham H. Jackson
The Oncologist 2005; 10(Supplement 1 ): 14-18; doi:10.1634/theoncologist.10-90001-14
[Abstract] [Full Text] [PDF]

Bisphosphonate Treatment Recommendations for Oncologists: Roger von Moos
The Oncologist 2005; 10(Supplement 1 ): 19-24; doi:10.1634/theoncologist.10-90001-19
[Abstract] [Full Text] [PDF]

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.

Cover Illustration:

Cover

Oriental Poppy by Bernique Longley.

Laudanum, or tincture of opium, was for many decades the only "treatment" for cancer in the Old West; the Oriental Poppy has, therefore, been chosen as the journal's icon.

HOME

HELP

SUBSCRIPTIONS